Research Program
Research Program
Immunology, Infection and Cancer
Coordinator Prof. Dr. Michael Platten
The newly founded Research Topic “Immunology, Infection and Cancer” focuses on the interactions of pathogens and the immune system and how they drive carcinogenesis, with the aim to develop novel immunotherapeutic approaches to cancer. The Topics missions are twofold:
(i) Understand immune reactivity to and develop effective immunotherapies for cancer through single cell analyses and targeted manipulation of immune cells from development through activation, and
(ii) Decipher pathogen/commensal – host interactions and mechanisms of (sterile) inflammation with the goal to devise prophylactic and therapeutic treatment lowering cancer burden.
We cover basic research to clinical implementation in the priority areas
(i) Immune Cell Development and Differentiation,
(ii) Host-Microbe Interactions in Health and Disease,
(iii) Cancer Inflammation and Immune Microenvironment,
(iv) Vaccine Development and Virotherapy, and
(v) T cell therapies.
In addition to programs to implement novel strategies to prevent and treat cancer at a national and global level via clinical trials, members of the Research Topic promote the transfer of new technologies into therapies through spin-outs.
News from Research Program "Immunology, Infection and Cancer"
Divisions
- Cellular Immunology Prof. Dr. Hans-Reimer Rodewald
- B Cell Immunology Prof. Dr. Hedda Wardemann
- Immune Diversity Prof. Dr. Nina Papavasiliou
- Structural Biology of Infection and Immunity Dr. Erec Stebbins
- Immunoproteomics Prof. Dr. Stefan Tenzer
- Personalized Immunotherapy Prof. Dr. Özlem Türeci
- mRNA Cancer Immunotherapies Prof. Dr. Ugur Sahin
- Tumor Immunology and Tumor Immunotherapy Prof. Dr. Niels Halama
- Molecular Oncology of Gastrointestinal Tumors Prof. Dr. Rienk Offringa
- Infections and Cancer Epidemiology Dr. Tim Waterboer
- Pathogenesis of Virus Associated Tumors Prof. Dr. Dr. Henri-Jacques Delecluse
- Immunotherapy and Immunoprevention PD Dr. Dr. Angelika Riemer
- DNA Vectors Dr. Richard Harbottle
- Virus-associated Carcinogenesis Prof. Dr. Dr. h. c. Ralf Bartenschlager
- Chronic Inflammation and Cancer Prof. Dr. Mathias Heikenwälder
- Microbiome and Cancer Prof. Dr. Eran Elinav
- Clinical Cooperation Unit Applied Tumor Immunity Prof. Dr. Dirk Jäger
- Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology Prof. Dr. med. Michael Platten
- Clinical Cooperation Unit Applied Tumor Biology Prof. Dr. med. Magnus von Knebel Doeberitz
- Clinical Cooperation Unit Virotherapy Prof. Dr. Dr. Guy Ungerechts
Other Units and Groups
- Junior Research Group Adaptive Immunity and Lymphoma M.D. Ph.D. Sandrine Sander
- Junior Research Group Dermal Oncoimmunology Dr. Hafsa Munir
- Junior Research Group Immune Regulation in Cancer Dr. Chong Sun
- Junior Research Group Systems Immunology and Single Cell Biology Dr. Felix Hartmann
- Junior Research Group Pediatric Immuno-Oncology Dr. Dr. Franziska Blaeschke
- Junior Research Group Epithelium Microbiome lnteractions Dr. Jens Puschhof
- Junior Research Group Experimental Hepatology, Inflammation and Cancer Dr. Dr. Michael Dill
- Research Group GMP & T Cell Therapy Prof. Dr. Stefan Eichmüller
- Research Group Tumorvirus-specific Vaccination Strategies apl. Prof. Dr. Martin Müller
- Research Group Mammalian Cell Cycle Control Mechanisms Prof. Dr. Ingrid Hoffmann
- Research Group Molecular Therapy of Virus-Associated Cancers Prof. Dr. Felix Hoppe-Seyler
- Research Group Episomal-Persistent DNA in Cancer- and Chronic Diseases Dr. Timo Bund
- DKFZ-Bayer Immunotherapeutics Lab Prof. Rienk Offringa / Dr. Rafael Carretero
- Immune Monitoring Unit Prof. Dr. Michael Platten